Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $889,917 - $1.19 Million
-9,010 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $115,368 - $174,129
1,051 Added 13.21%
9,010 $1.12 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $365,748 - $515,628
2,879 Added 56.67%
7,959 $1.22 Million
Q4 2020

Feb 08, 2021

BUY
$99.96 - $135.93 $305,577 - $415,538
3,057 Added 151.11%
5,080 $655,000
Q3 2020

Nov 12, 2020

BUY
$80.32 - $111.8 $162,487 - $226,171
2,023 New
2,023 $226,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.